Dextranomer in stabilized sodium hyaluronate (Solesta®): In adults with faecal incontinence

Drugs

Volumn 72, Issue 12, 2012, Pages 1671-1678

  Hoy, Sheridan M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Drug Profiles; Dextranomer; Faecal incontinence

Indexed keywords

DEXTRANOMER; DEXTRANOMER IN STABILIZED SODIUM HYALURONATE; HYALURONIC ACID; SOLESTA; UNCLASSIFIED DRUG;

ANORECTAL DISCOMFORT; ANORECTAL DISEASE; ANUS PRURITUS; ARTICLE; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG FEVER; DRUG TOLERABILITY; FECAL INCONTINENCE QUALITY OF LIFE DOMAIN SCORE; FECES INCONTINENCE; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE PAIN; PROCTALGIA; QUALITY OF LIFE INDEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM HEMORRHAGE; RECTUM PROLAPSE;

DEXTRANS; DOUBLE-BLIND METHOD; FECAL INCONTINENCE; HUMANS; HYALURONIC ACID; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84864688295     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11209030-000000000-00000     Document Type: Article

References (17)

1. Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Co-chrane Database Syst Rev 2010; (5): CD007959
2. Mellgren A. Fecal incontinence. Surg Clin North Am 2010; 90 (1): 185-94
3. Whitehead WE, Borrud L, Goode PS, et al. Fecal incon- tinence in US adults: epidemiology and risk factors. Gas-troenterology 2009 Aug; 137 (2): 512-7, 517.e1-2
4. Engel AF, Kamm MA, Bartram CI, et al. Relationship of symptoms in faecal incontinence to specific sphincter ab-normalities. Int J Colorectal Dis 1995; 10 (3): 152-5
5. Graf W, Mellgren A, Matzel KE, et al. Efficacy of dex- tranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet 2011; 377 (9770): 997-1003
6. Brown SR, Wadhawan H, Nelson RL. Surgery for faecal incontinence in adults. Cochrane Database Syst Rev 2010; (9): CD001757
7. Solesta® package insert. Edison: Oceana Therapeutics, Inc., 2011 8. US Food and Drug Administration. Summary ofsafety and effectiveness data online. Available from URL: http:// www.accessdata.fda.gov/cdrh/docs/pdf10/P100014b.pdf Ac-cessed 2012 Jul 24
8. Danielson J, Karlbom U, Sonesson A-C, et al. Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incon-tinence. Dis Colon Rectum 2009; 52 (6): 1101-6
9. Dodi G, Jongen J, de la Portilla F, et al. An open-label, noncomparative, multicenter study to evaluate efficacy and safety of NASHA/Dx gel as a bulking agent for the treat-ment offecal incontinence. Gastroenterol Res Pract 2010: 467136
10. Olivera C, Garely A. Efficacy ofdextranomer in stabilized hyaluronic acid (Solesta®) for treatment of fecal incon-tinence secondary to obstetric trauma abstractno. NM17. Neurourol Urodynam 2012 Feb; 31 (2): 271-2
11. La Torre F. Long term efficacy ofdextranomer in stabilized hyaluronic acid (Solesta) for treatment of fecal incon-tinence (FI) abstractno. LTP44. Colorectal Dis 2011; 13 Suppl. S6: 21
12. Mellgren A, Pollack J, Matzel K, et al. Long-term efficacy of NASHA/Dx injection therapy (Solesta) for treatment of fecal incontinence abstract no. 46. Dis Colon Rectum 2012; 55 (5): 35
13. Dehli T, Mevik K, Stordahl A, et al. A randomized, con- trolled study of biofeedback and dextranomere (Solesta) injection for treatment of anal incontinence abstract no. B6. Colorectal Dis 2010; 12 Suppl. S3: 1
14. Rockwood TH, Church JM, Fleshman JW, et al. Fecal In- continence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 2000 Jan; 43 (1): 9-16; discussion 16-7
15. US Food and Drug Administration. FDA approves in- jectable gel to treat fecal incontinence online. Available from URL: http://www.fda.gov/NewsEvents/ Newsroom/ PressAnnouncements/ucm257112.htm Accessed 2012 Jul 24
16. Q-Med. Solesta received approval in Europe for treatment of fecal incontinence media release. 2011 Nov 30 online. Available from URL: http://www.q-med.com/Pressroom/ press-releases/ Accessed 2012 Jul 24
17. Norton C. Treating faecal incontinence with bulking-agent injections. Lancet2011; 377 (9770): 971-2